SH2D2A: A Protein Target for Drug Development and Diagnosis (G9047)

Target Name: SH2D2A

NCBI ID: G9047

SH2D2A

SH2D2A: A Protein Target for Drug Development and Diagnosis

SH2D2A (Splice Hire 2 Domain 2 Subunit A) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a key component of the Sh2D2A complex, which is involved in the regulation of DNA replication and repair.

Recent studies have identified SH2D2A as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because SH2D2A has been shown to play a role in the development and progression of these conditions, and may also be involved in their treatment.

One of the reasons for the potential of SH2D2A as a drug target is its location in the genome. It is located on chromosome 16, which is one of the most commonly used chromosomes for drug targets. This makes it more accessible to researchers and clinicians who are looking for new treatments.

In addition, SH2D2A is known to be involved in a variety of cellular processes that are important for human health. It is involved in the regulation of cell division, DNA replication and repair, and cell signaling. This makes it a likely candidate for a variety of therapeutic interventions.

Another potential reason for the interest in SH2D2A as a drug target is its role in the development of certain diseases. For example, SH2D2A has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. It is also involved in the development of certain autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis.

In addition to its potential as a drug target, SH2D2A is also a potential biomarker for a variety of diseases. This is because it is often expressed at higher levels in the brains and other organs of people with certain diseases. This makes it a potential indicator of the presence of these diseases, and could be used for diagnostic purposes.

One of the challenges in studying SH2D2A as a drug target is its complexity. It is a protein that is involved in many different cellular processes, and it is not clear exactly how it interacts with other proteins. This makes it difficult to understand how it works and how it could be targeted by drugs.

Despite these challenges, recent studies have provided some important insights into the role of SH2D2A in human health and disease. For example, studies have shown that SH2D2A is involved in the regulation of cell division and that it plays a role in the development of certain diseases. Additionally, studies have identified SH2D2A as a potential drug target and a potential biomarker for a variety of diseases.

In conclusion, SH2D2A is a protein that is expressed in various tissues of the human body and is involved in the regulation of DNA replication and repair. Its potential as a drug target and biomarker for various diseases makes it a promising target for future research and clinical development. Further studies are needed to fully understand its role in human health and disease.

Protein Name: SH2 Domain Containing 2A

Functions: Could be a T-cell-specific adapter protein involved in the control of T-cell activation. May play a role in the CD4-p56-LCK-dependent signal transduction pathway. Could also play an important role in normal and pathological angiogenesis. Could be an adapter protein that facilitates and regulates interaction of KDR with effector proteins important to endothelial cell survival and proliferation

The "SH2D2A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SH2D2A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets